Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Free Cash Flow (2023 - 2025)

Incannex Healthcare (IXHL) has disclosed Free Cash Flow for 3 consecutive years, with -$4.6 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 18.18% to -$4.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$18.4 million through Dec 2025, down 16.63% year-over-year, with the annual reading at -$12.5 million for FY2025, 22.12% up from the prior year.
  • Free Cash Flow hit -$4.6 million in Q4 2025 for Incannex Healthcare, up from -$9.2 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$1.5 million in Q2 2025 to a low of -$9.2 million in Q3 2025.
  • Historically, Free Cash Flow has averaged -$4.2 million across 3 years, with a median of -$4.0 million in 2024.
  • Biggest five-year swings in Free Cash Flow: skyrocketed 63.15% in 2024 and later tumbled 316.59% in 2025.
  • Year by year, Free Cash Flow stood at -$2.2 million in 2023, then tumbled by 162.35% to -$5.7 million in 2024, then rose by 18.18% to -$4.6 million in 2025.
  • Business Quant data shows Free Cash Flow for IXHL at -$4.6 million in Q4 2025, -$9.2 million in Q3 2025, and -$1.5 million in Q2 2025.